O le lata mai in vitro faʻataʻitaʻi alamanuia amataina i se vaitaimi o le vave atinaʻe

Novel coronavirus niumonia novel coronavirus niumonia o le sili ona taua faʻamuamua i faʻamuamua. O le novel coronavirus pneumonia (IVD) alamanuia o le a atiaʻe faʻavave ma le vave atinaʻe o tele fou tekonolosi ma le faʻatupuina o fou pale mama. O loʻo faʻamoemoe e avea ma se tasi o maketi pito sili ona mataʻalia ma televave atinaʻe ile vaega o meafaigaluega faʻafomaʻi ile lumanaʻi.

Tekinolosi fou, fou auala ma fou manaʻomia tatalaina avanoa fou

Faatasi ai ma le televave atinae o biotechnology, o le maketi fua o le lalolagi i vitro diagnosis alamanuia ua faatupulaia vave. E tusa ai ma faʻamaumauga a Saina i vitro diagnostic network (caivd), i le 2013, o le maketi tele o le lalolagi i vitro diagnostic pisinisi e tusa ma le US $ 60 piliona, ma ua ova atu i le US $ 80 piliona i le 2019, faatasi ai ma le averesi lotogatasi faʻatupulaia tuputupu aʻe o le 6%. O loʻo iai le faʻamoemoe o le tau o le maketi o le a sili atu i le US $ 90 piliona i le 2020 (tagai Ata 1 mo 

fbg

E tusa ai ma le mauaina o mataupu faʻavae ma metotia, e mafai ona vaevaeina i ono tele matata: immunodiagnosis, biokimia faʻamaʻi, faʻamaoniga o le toto, faʻamaoniga mole mole, faʻamaoniga o meaola niniʻi ma faʻataʻitaʻiga vave (POCT). Mai le atinaʻe tulaga o le lalolagi i vitro diagnostic maketi, i tausaga talu ai nei, o le maketi faʻasoa o falemaʻi biochemical faʻamaoniga ma immunodiagnosis oloa ua fai sina paʻu, a o le maketi faʻasoa o nucleic acid faʻailogaina, microbiology, tala faʻasolopito ma tafe cytometry ua faʻateleina tausaga i lea tausaga, ma le averesi tuufaatasiga faʻateleina tuputupu aʻe fua faatatau o le sili atu i le 10%. I le 2019, immunodiagnosis o loʻo pito sili ona tele lona sea, faʻatau mo le 23%, sosoʻo mai ai ma suʻesuʻega o le biochemical, e maua ai le 17% (vaʻai le Ata 2 mo faʻamatalaga).

kjd3

I tausaga ua tuanaʻi, o tekonolosi fou ma faʻataʻitaʻiga o le lalolagi i in vitro diagnostic industry ua aliali mai. Tekinolosi suʻesuʻega molecular faʻataʻitaʻia e le lua augatupulaga faʻasologa o faʻasologa (NGS), moni-taimi mauaina oloa faʻatusalia e microfluidic chips, ma fou tekonolosi ma faʻataʻitaʻiga e pei o ona po nei pulega soifua maloloina ma le saʻo togafitiga faʻafomaʻi, sui e tele faʻamatalaga ma Initaneti faʻaopoopoina, ua tatalaina potu fou mo le in vitro diagnostic industry. Faʻatasi ai ma le faʻaauau pea o le faʻaleleia o in vitro diagnostic tekinolosi ma le lautele faʻaaogaina o fesoʻotaʻiga faʻasaienisi mataʻutia ma tekonolosi, o le lalolagi i vitro diagnostic maketi o le a faʻatumauina se alualu i luma tuputupu aʻe. I se faʻaopopoga, o le lalolagi faitau aofaʻi nofoaga o loʻo faʻateleina, ma o le siʻitia ai fua faatatau o faʻamaʻi masani, kanesa ma isi faʻamaʻi ua faʻateleina. E faʻalauiloa ai foʻi le faʻaauau pea o le atinaʻe o le in vitro diagnostic market.

Uunaia e le saoasaoa o le faitau aofai o tagata matutua, fou tekonolosi breakthrough ma faiga faavae tufatufaina, le in vitro diagnosis pisinisi i Saina ua atiina ae faifai pea. I tausaga talu ai nei, o le aiga in vitro diagnosis alamanuia ua atiina ae vave, o nisi pisinisi i le lotoifale ua faia mea alualu i luma i tekonolosi, ma nisi o lotoifale pisinisi ua tulaʻi televave unaʻia e le tele maketi totonu o le atunuʻu manaʻoga. I se faʻaopopoga, i tausaga ua tuanaʻi, na faʻasolosolo lava ona tuʻuina mai e Saina se faʻasologa o faiga faʻavae e lagolago ai le atinaʻeina o in vitro diagnosis industry. Mo se faʻataʻitaʻiga, e i ai fesoʻotaʻiga lagolagoina aiaiga i le 13th lima tausaga fuafuaga mo vailaʻau masini faʻasaienisi ma tekonolosi fou, 13th lima tausaga fuafuaga mo biotechnology fou ma maloloina Saina 2030 fuafuaga faʻatulagaina, lea atili faʻaosofia ai le taua o le pisinisi.

 

O loʻo i ai maketi o loʻo tulaʻi mai

I le aotelega, o le atinaʻeina o le lalolagi IVD maketi e matua le tutusa. Mai le vaaiga o le tufatufaina faʻaitulagi, Amerika i Matu, Sisifo o Europa ma isi tamaoaiga atinaʻe itulagi tala mo sili atu i le 60% o le maketi faʻasoa; mai le vaʻaiga a pisinisi maketi faʻasoa, toeititi afa o le maketi faʻasoa e ave e Roche, Abbott, Siemens ma Danaher. O Saina o se maketi o loʻo amata mai in vitro diagnosis industry, lea o loʻo i totonu o le vaitaimi o le faʻatupulaia vave i le taimi nei ma e mafai ona faʻamoemoeina i le lumanaʻi.

I le taimi nei, o atinaʻe tamaoaiga e pei o Amerika i Matu ma Europa i Sisifo, e sili atu ma le 60% o le lalolagi o in vitro diagnostic market. Ae ui i lea, o atunuʻu atinaʻe ma maketi faʻaitumalo ua ofi atu i se matua tulaga ma faʻamautuina mautu atinae ma tuai lemu. I atunuʻu atiaʻe, i le avea ai o se alamanuia alualu i luma, in vitro faʻailoga ei ai uiga o laʻititi faʻavae ma maualuga tuputupu aʻe. O loʻo faʻamoemoeina i maketi fou o loʻo fai ma sui o Saina, Initia ma isi atunuʻu ma itulagi, o le tuputupu aʻe o le maketi o le vitro diagnosis o le a tumau i le 15% ~ 20%. O le maketi fou o le a avea ma se tasi o sili ono ono vaega o in vitro diagnosis pisinisi.

mka2

Saina i in vitro diagnose alamanuia amataina i le faaiuga o le 1970s ma ua i ai nei i se vaitaimi o le vave atinae. I le 2019, o le maketi fuaina o Saina i vitro diagnosis alamanuia e latalata i le 90 piliona yuan, ma le averesi faaletausaga tuufaatasiga tupu fua o le sili atu nai lo 20%. I le tuanaʻi 10 tausaga, sili atu nai lo le 20 lotoifale in vitro diagnostic pisinisi ua faʻamanuiaina ausia IPO, ma Mindray faʻafomaʻi, Antu moni, BGI ma Wanfu mea ola ua avea ma taimua pisinisi i a latou vaega. Nisi o mea lautele faʻaaogaina (pei o le suʻesuʻeina o meaola ma faʻataʻitaʻiga vave) ua oʻo i le tulaga maualuga faʻavaomalo i le vaitaimi lava e tasi. Tutusa ma maketi faʻavaomalo, Roche, Abbott, Danaher, Siemens ma hysenmecon teuga tupe mo le sili atu i le 55% o Saina IVD maketi. Kamupani faavaomalo faʻaaoga a latou tulaga lelei i oloa, tekonolosi ma tautua e faʻaauau ai pea ona faʻateleina a latou tupe teu tupe i Saina, aemaise lava i falemaʻi maualuluga a le atunuʻu ma isi maketi maualuluga, lea e masani ai ona maualuga atu le tau nai lo oloa a le atunuʻu. I le tausaga nei puipuiga coronavirus puipuia ma le puleaina, o le lotoifale in-vitro diagnostic pisinisi faʻaali mai o latou mata pupula. O le lona tolu pati suʻesuʻe kamupani ua faʻaleleia lona tulaga i le fomaʻi faʻagaioiga, ma ua fuafuaina e faia tele faʻamaʻi gaioiga galuega.

 

In vitro diagnostic reagents o oloa tiaʻi tagata lafoa, ma o le stock market manaoga o le a le solomuli. O le fale i in vitro diagnostic market e mamao lava mai le oʻo atu i le "taualuga". O loʻo tele pea fanua le faʻamaʻaina e atiaʻe, ma ole pisinisi o le a tumau i se mautu ma vave atinaʻe aga i le lumanaʻi.

 

Manatu lelei mo tolu tetele vaega

I le maeʻa ai o le vaitaimi o faʻamaʻi, o le Saina i in vitro diagnose alamanuia o le a ulufale i se vaitaimi o le malosi atinaʻe i mole mole, immunodiagnosis ma vave faʻamaoniga.

 

Vaʻai faʻamaʻi

I le taimi nei, o le maketi tuputupu aʻe o molelaula faʻamaʻi alamanuia i Saina e vave, o le alamanuia faʻatatau e maualalo, o le tekonolosi va i le va o totonu o le atunuʻu ma fafo pisinisi e laʻititi, ma taʻitasi atinaʻe ei ai a latou lava fanua o tomai.

 

E tusa ai ma fuainumera, i le 2019, o le maketi fuaina o Saina o fualaʻau mole fua faatatau pisinisi e tusa ma le 11.58 piliona yuan; o le averesi faʻaletausaga tuputupu aʻe fua faatatau mai 2011 i le 2019 o le a oʻo atu i le 27%, tusa ma le faalua le lalolagi tuputupu aʻe fua faatatau. I totonu o Saina fualaʻau faʻamaʻi mole mole, pisinisi mai fafo faʻatupeina faʻatupeina mo 30% o le maketi, tele faʻapitoa tuʻufaʻatasia i le pito i luga o le alamanuia filifili, ma oloa o Roche, Abbott's aofaʻi PCR ma IL Lumina's sequencer o le sui; O pisinisi a le atunuʻu e 70% le maketi o oloa, ma o le latou pisinisi e tele lava ina faʻamuamua ile PCR diagnostic reagents ma ngs diagnostic services. O le aufaipisinisi sui e aofia ai Kaipu biology, fesoasoani fesoasoani, Huada gene, berry gene, Zhijiang biology, Daan gene, etc.

 

E tele tagata o loʻo auai ile maketi o faʻamaʻi mole molemole i Saina, ma e maualalo le faʻatinoina o pisinisi. O le mafuaʻaga autu o lenei mea faigata o le falemaʻi manaʻomia aofia i mole mole e tele ma faigata, ma taʻitasi tagata auai maketi i ai a latou lava faʻatekinisia uiga ma vaega o tomai, o lea e faigata ai ona aofia uma pisinisi, o lea e faigata ai ona fausia. o se faʻataʻitaʻiga iloga.

 

Molecular diagnosis tekinolosi faʻapitoa aofia ai PCR, iʻa, faʻasologa o gafa ma gaʻo sela. I se taimi umi, o le atinaʻe avanoa o gafa faʻasologa o tekonolosi e lautele atu, ae o lona tau e maualuga atu. O le tekonolosi a le PCR o loʻo avea pea ma tekonolosi taua i le matata o faʻamaoniga mole mole. Ina ia mafai ona faia se galuega lelei i faʻamaʻi puipuia ma le faʻatonutonuina, o le tele o aiga fualaʻau mole faʻataʻitaʻiga atinaʻe ua faʻasolosolo lelei atinae fou coronavirus nucleic acid mauaina ato, ma o le tele o nei ato e faʻaaogaina fluorescent tele PCR tekonolosi, lea e taua tele i le faʻamaʻi puipuiga ma faʻatonutonu, ma unaʻia le atoa vaega o faʻataʻitaʻiga mole poloka ia maua se faʻamoemoe lelei.

Immunodiagnosis

I le taimi nei, immunodiagnosis maketi o le sili ona tele maketi vaega o in vitro diagnosis pisinisi i Saina, fuafua mo tusa 38% o le atoa in vitro diagnosis maketi.

mak1

Sili atu 60% o le maketi sea o immunodiagnosis i Saina o loʻo nofoia e fafo-faʻatupeina pisinisi, ae na o le 30% o le maketi faʻasoa o lotoifale pisinisi pei o Mindray faʻafomaʻi, Mike moni, Antu moni, ma isi o loʻo nofoia, ma le pisinisi ua maualuga le uaʻi O loʻo faʻatupeina e kamupani mai fafo ni pisinisi e 80% ~ 90% ole faʻasologa maualuga o maketi i Saina ma latou tekonolosi mea lelei mo le tele o tausaga, ma o latou tagata faʻatau e tele lava falemaʻi tele; atinaʻe i le lotoifale faʻatelevaveina le faʻagasologa o suiga i totonu o le atunuʻu e ala i le lelei o le faʻatinoina o tau ma tutusa tutusa.

 

Vave faʻamaoniga

Sa amata tuai le maketi o suʻesuʻega a Saina, ma o le aofaʻi o maketi e laʻititi. Ae ui i lea, i tausaga talu ai nei, o le maketi tuputupu aʻe fua faatatau na tumau pea i le 10% ~ 20%, sili atu maualuga nai lo le lalolagi tuputupu aʻe fua faatatau o 6% ~ 7%. E tusa ai ma faʻamaumauga, i le 2018, o le Saina maketi taimi faʻapitoa suʻesuʻega o le a oʻo atu i le 6.6 piliona yuan, e oʻo atu i le 7.7 piliona yuan i le 2019; Roche, Abbott, merier ma isi pisinisi faʻatupeina mai fafo o le a nofoia se tulaga sili ona maualuga i le China-maualuga-iuga-taimi tonu maketi faʻataʻitaʻiga, ma le maketi faʻasoa e uiga i le 90%; atinaʻe i le lotoifale o loʻo faasolosolo lava ina ova i luga o le piʻoga ma o latou tau lelei ma tekonolosi fou.

 

Suʻesuʻega vave e mafai ona vave maua ai iʻuga, e le faʻatapulaʻaina e le nofoaga suʻega, ae manaʻomia foi le maualalo tomai faʻapitoa o tagata faʻagaioia. E fetaui lelei mo mutia-aʻoga falemaʻi falemaʻi, faʻapea foi ma falemaʻi tetele, e pei o faʻalavelave faʻafuaseʻi, outpatient, muamua-operative faʻamaʻi pipisi faʻamaʻi, nosocomial siama siaki, ulufale-ulufale luga-nofoaga mauaina, ulufale-ulu tagata lava ia asiasiga ma isi tulaga . O le mea lea, talafeagai, miniaturized ma talafeagai mo vave siakiina o le moni-taimi faʻataʻitaʻiina o oloa o le a taua tele le taua i le atinaʻeina o in vitro diagnosis pisinisi i le lumanaʻi. I le taimi nei, o le sui taimi moni-taimi faʻamaoniga pisinisi i Saina aofia Wanfu biology, Jidan biology, Mingde biology, Ruilai biology, Dongfang gene, Aotai biology, etc.

 

E ala i le auiliiliina iloiloina o le aafiaga o le faamaʻi tulaga ma le maketi atinae faamoemoe, tatou mafai ona iloa ai o le maketi atinae tulaga ma Prospect o mole mole, puipuia puipuia ma vave faʻataʻitaʻi e lelei. Faatasi ai ma lona taua matafaioi i faʻamaʻi puipuia ma le faʻatonutonu, in vitro faʻamaoniga o le a sili atu ona popole ma amanaʻia e le maketi, ma o le a avea ma se tasi o sili ona ono vaega i le falemaʻi masini pisinisi i isi tausaga.


Taimi Post: Tes-18-2020